Early experience with high‐intensity focused ultrasound for the treatment of benign prostatic hypertrophy

Sullivan, Lorne D.; McLoughlin, Martin G.; Goldenberg, Limor; Gleave, M.E.; Marich, Kenneth W.

doi:10.1046/j.1464-410x.1997.03235.x

Cited by 38 publications

(16 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…HIFU irradiates highly focused ultrasound transrectally into the prostate to create coagulation necrosis. Several clinical studies have reported that HIFU significantly improves symptoms, QOL, and Q max 237–239 . HIFU was comparable to transurethral microwave thermotherapy (TUMT) and transurethral needle ablation (TUNA) in improving LUTS over a 2‐year follow‐up period 240 .…”

Section: Surgical Treatment (Surgical Therapy)mentioning

confidence: 99%

JUA clinical guidelines for benign prostatic hyperplasia

et al. 2011

View full text Add to dashboard Cite

Abstract:The Japanese Urological Association has developed Clinical Guidelines for Benign Prostatic Hyperplasia (BPH) for men with suspected BPH. This article is an English translation of the abridged version of the Guidelines. The Guidelines were formulated on the basis of evidence retrieved from the PubMed database between 1995 and 2009, as well as other relevant sources. The target patients of these Guidelines are men with suspected BPH, and the target users are urologists. A mandatory assessment should include a medical history, a physical examination, the completion of symptom and quality of life questionnaires, a urinalysis, a prostate ultrasonography, measurement of serum prostate specific antigen and postvoid residual urine, and uroflowmetry. Optional tests include keeping a bladder diary, the measurement of serum creatinine, and upper urinary tract ultrasonography. Care should be taken to not overlook coexisting diseases such as infections or malignancies that may obscure the diagnosis. Treatment should consist of conservative therapy or the use of medications such as a1-adrenoceptor antagonists, or both. The use of 5a-reductase inhibitors or anticholinergic agents should be considered in patients with an enlarged prostate (>30 mL) or overactive bladder symptoms (Overactive Bladder Symptom Score Ն6), respectively. Surgical intervention is indicated when non-surgical treatments fail to provide sufficient symptomatic relief, and when bladder outlet obstruction is highly suspected.

show abstract

Section: Surgical Treatment (Surgical Therapy)mentioning

confidence: 99%

JUA clinical guidelines for benign prostatic hyperplasia

et al. 2011

View full text Add to dashboard Cite

show abstract

“…A catheter is placed to drain the bladder throughout the procedure and remains in place for about 2 weeks. 31,32 The high temperatures achieved necessitate general anaesthesia or sedoanalgesia with the procedure carried out as a day case. …”

mentioning

confidence: 99%

Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement

Lourenço

Armstrong²,

N’Dow³

et al. 2008

Health Technol Assess

117

View full text Add to dashboard Cite

Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement. Lourenco, T.; Armstrong, N.; N'Dow, J.; Nabi, G.; Deverill, M.; Pickard, R.; Vale, L.; MacLennan, G.; Fraser, C.; McClinton, S.; Wong, S.; Coutts, A.; Mowatt, G.; Grant, A. Published in: Health Technology Assessment Publication date: 2008 Document VersionPublisher's PDF, also known as Version of record Link to publication in Discovery Research Portal Citation for published version (APA):Lourenco, T., Armstrong, N., N'Dow, J., Nabi, G., Deverill, M., Pickard, R., ... Grant, A. (2008). Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement. Health Technology Assessment, 12(35). General rightsCopyright and moral rights for the publications made accessible in Discovery Research Portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.• Users may download and print one copy of any publication from Discovery Research Portal for the purpose of private study or research.• You may not further distribute the material or use it for any profit-making activity or commercial gain.• You may freely distribute the URL identifying the publication in the public portal. Take down policyIf you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Download date: 12. May. 2018 Health Technology Assessment 2008; Vol. 12: No. 35 Health Technology Assessment NIHR HTA Programme www.hta.ac.uk November 2008 Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement How to obtain copies of this and other HTA Programme reports. An electronic version of this publication, in Adobe Acrobat format, is available for downloading free of charge for personal use from the HTA website (www.hta.ac.uk). A fully searchable CD-ROM is also available (see below).Printed copies of HTA monographs cost £20 each (post and packing free in the UK) to both public and private sector purchasers from our Despatch Agents.Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. NHS libraries can subscribe free of charge. Public libraries can subscribe at a very reduced cost of £100 for each volume (normally comprising 30-40 titles). The commercial subscription rate is £3...

show abstract

“…Sullivan et al [8] used SB-HIFU for the treatment of 25 patients with BPH. Our results were similar to theirs, showing that HIFU was a promising technique for the relief of prostate obstruction.…”

Section: Discussionmentioning

confidence: 99%

Sonablate-500™ transrectal high-intensity focused ultrasound (HIFU) for benign prostatic hyperplasia patients

Lü

Wang

2007

J. Huazhong Univ. Sci. Technol. [Med. Sci.]

View full text Add to dashboard Cite

To evaluate the safety and efficacy of transrectal high-intensity focused ultrasound (HIFU) in the treatment of benign prostatic hyperplasia (BPH), serial studies were conducted in 150 BPH patients before and 30 min, 1, 2, 6 and 12 month(s) after Sonablate-500 HIFU treatment. A silicon-coated indwelling 16F latex catheter was placed during the determination of the therapy zone. Preoperative and postoperative evaluations were made by using the international prostate symptom score (IPSS), quality of life (QOL), uroflowmetric findings and transrectal ultrasound, and incidence of complications. The cystourethrography was done in 23 patients within 1 year postoperatively. The results showed that after HIFU treatment, IPSS and QOL scores were significantly decreased at 1, 2, 6 and 12 month(s) (P<0.01). Maximum urine flow rate (6.0 to 17.2 mL/s, P<0.01), PVR (75.0 to 30.3, P<0.01) and prostatic volume (65.0 to 38.1 mL, P<0.05) were significantly improved 12 months after the operation. Recurrent urinary retention (n=2) and urethrorectal fistula (n=1) occurred at the 15(th) postoperative day. The duration of the HIFU prostate ablation was 25-90 min. The mean time for an indwelling catheter was 3-19 days. These data demonstrate that treatment of BPH with Sonablate-500 HIFU is safe and effective.

show abstract

Early experience with high‐intensity focused ultrasound for the treatment of benign prostatic hypertrophy

Cited by 38 publications

References 0 publications

JUA clinical guidelines for benign prostatic hyperplasia

JUA clinical guidelines for benign prostatic hyperplasia

Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement

Sonablate-500™ transrectal high-intensity focused ultrasound (HIFU) for benign prostatic hyperplasia patients

Contact Info

Product

Resources

About